Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
---|---|---|---|---|---|---|---|---|---|---|---|---|
IFRX | INFLARX NV | $81.26M | $68.58k | -$45.72M | -$46.38M | -$0.85 | N/A | N/A | N/A | N/A | 2024-05-08 | |
LQDA | LIQUIDIA CORP | $972.40M | $17.49M | -$69.65M | -$78.50M | -$1.21 | 9.75% | 45.23% | N/A | N/A | 2024-06-20 | |
ATAI | ATAI LIFE SCIENCES NV | $340.35M | $314.00k | -$35.85M | -$40.22M | -$0.25 | 34.76% | N/A | N/A | N/A | 2024-05-07 | |
GLMD | GALMED PHARMACEUTICALS LTD | $1.95M | $0.00 | -$7.46M | -$6.91M | -$2.50 | N/A | -100.00% | N/A | N/A | 2024-05-30 | |
AUPH | AURINIA PHARMACEUTICALS INC | $729.40M | $191.41M | -$41.87M | -$62.56M | -$0.42 | 30.37% | 233.64% | N/A | N/A | 2024-06-14 | |
BEAM | BEAM THERAPEUTICS INC | $1.89B | $377.71M | -$111.15M | -$132.53M | -$1.72 | 520.01% | N/A | N/A | N/A | 2024-06-05 | |
CASI | CASI PHARMACEUTICALS INC | $37.39M | $33.88M | -$22.29M | -$26.96M | -$2.02 | -21.41% | N/A | N/A | N/A | ||
NRBO | NEUROBO PHARMACEUTICALS INC | $18.54M | $0.00 | -$12.46M | -$12.47M | -$2.46 | N/A | N/A | N/A | N/A | 2024-06-07 | |
BLUE | BLUEBIRD BIO INC | $98.40M | $21.73M | -$95.08M | -$91.17M | -$0.60 | 322.60% | -11.27% | N/A | N/A | 2024-06-14 | |
HOTH | HOTH THERAPEUTICS INC | $5.33M | $0.00 | -$7.85M | -$7.85M | -$2.30 | N/A | N/A | N/A | N/A | 2024-05-15 | |
MTEM | MOLECULAR TEMPLATES INC | $8.98M | $57.31M | $1.16M | -$8.12M | $1.80 | 190.10% | 33.96% | -92.71% | N/A | 2024-05-13 | |
ARVN | ARVINAS INC | $2.23B | $78.50M | -$359.70M | -$367.30M | -$6.62 | -40.26% | 40.53% | N/A | N/A | 2024-05-29 | |
MESO | MESOBLAST LTD | $761.10M | $7.25M | N/A | -$73.06M | -$0.91 | -5.28% | -14.93% | N/A | N/A | 2024-05-30 | |
CRBU | CARIBOU BIOSCIENCES INC | $340.49M | $34.48M | -$96.30M | -$102.07M | -$1.38 | 148.91% | N/A | N/A | N/A | 2024-05-07 | |
YMAB | Y-MABS THERAPEUTICS INC | $750.78M | $84.82M | -$24.94M | -$21.43M | -$0.49 | 29.96% | N/A | N/A | N/A | 2024-05-07 | |
LIFE | ATYR PHARMA INC | $111.11M | $588.00k | -$51.17M | -$53.93M | -$0.90 | -94.34% | N/A | N/A | N/A | 2024-05-22 | |
CUE | CUE BIOPHARMA INC | $103.61M | $5.49M | -$46.05M | -$50.73M | -$1.11 | 340.96% | 36.88% | N/A | N/A | 2024-06-05 | |
PGEN | PRECIGEN INC | $353.47M | $6.23M | -$89.23M | -$95.90M | -$0.39 | -76.87% | -47.16% | N/A | N/A | 2024-06-07 | |
CCCC | C4 THERAPEUTICS INC | $462.37M | $20.76M | -$121.80M | -$132.49M | -$2.67 | -33.25% | 1.40% | N/A | N/A | 2024-06-20 | |
ARDX | ARDELYX INC | $2.04B | $159.11M | -$53.48M | -$65.81M | -$0.29 | 152.32% | 253.80% | N/A | N/A | 2024-06-14 | |
IKNA | IKENA ONCOLOGY INC | $63.70M | $9.16M | -$65.59M | -$68.17M | -$1.63 | -41.35% | N/A | N/A | N/A | 2024-06-07 | |
CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC | $5.96M | $9.00k | -$5.19M | -$5.29M | -$3.76 | -89.84% | -40.86% | N/A | N/A | 2024-05-10 | |
LYRA | LYRA THERAPEUTICS INC | $245.69M | $1.68M | -$68.69M | -$68.88M | -$1.20 | 28.74% | N/A | N/A | N/A | 2024-06-13 | |
QTTB | Q32 BIO INC | $82.65M | $1.16M | -$110.32M | -$112.96M | -$35.10 | -63.97% | -26.32% | N/A | N/A | 2024-06-13 | |
ALLO | ALLOGENE THERAPEUTICS INC | $519.11M | $95.00k | -$313.07M | -$327.27M | -$2.09 | -39.10% | N/A | N/A | N/A | 2024-06-05 | |
MIST | MILESTONE PHARMACEUTICALS INC | $89.82M | $1.00M | -$57.04M | -$59.69M | -$1.39 | -80.00% | N/A | N/A | N/A | 2024-06-13 | |
PRTC | PURETECH HEALTH PLC | $773.99M | $3.33M | -$30.24M | -$65.70M | -$2.40 | -78.68% | -30.64% | N/A | N/A | 2024-06-12 | |
XOMA | XOMA CORP | $288.09M | $4.76M | -$39.24M | -$46.30M | -$4.04 | -21.06% | -2.13% | N/A | N/A | 2024-05-07 | |
NTLA | INTELLIA THERAPEUTICS INC | $2.27B | $36.28M | -$472.22M | -$481.19M | -$5.42 | -30.40% | 3.57% | N/A | N/A | 2024-06-03 | |
PLUR | PLURI INC | $29.81M | $357.00k | -$21.99M | -$23.95M | -$4.64 | 10.53% | 48.16% | N/A | N/A | 2024-06-25 | |
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $774.51M | $59.61M | -$227.43M | -$262.14M | -$3.78 | 1,517.09% | N/A | N/A | N/A | 2024-06-14 | |
DNLI | DENALI THERAPEUTICS INC | $2.39B | $330.53M | -$128.47M | -$145.22M | -$1.06 | 204.74% | 20.67% | N/A | N/A | 2024-05-06 | |
LYEL | LYELL IMMUNOPHARMA INC | $599.67M | $130.00k | -$214.38M | -$234.63M | -$0.93 | -99.85% | N/A | N/A | N/A | 2024-05-07 | |
SPRC | SCISPARC LTD | $890.42k | $767.73k | $1.80M | $1.37M | -$3.85 | 108.44% | N/A | N/A | N/A | ||
IMNM | IMMUNOME INC | $940.18M | $14.02M | -$106.08M | -$106.81M | -$5.38 | N/A | N/A | N/A | N/A | 2024-06-12 | |
KROS | KEROS THERAPEUTICS INC | $2.18B | $151.00k | -$150.63M | -$152.99M | -$5.20 | N/A | -56.77% | N/A | N/A | 2024-05-30 | |
GLYC | GLYCOMIMETICS INC | $117.94M | $10.00k | -$35.89M | -$36.90M | -$0.58 | -86.67% | N/A | N/A | N/A | 2024-05-09 | |
INO | INOVIO PHARMACEUTICALS INC | $282.78M | $832.01k | -$130.39M | -$135.12M | -$6.09 | -91.89% | -51.33% | N/A | N/A | 2024-05-15 | |
MRNS | MARINUS PHARMACEUTICALS INC | $82.51M | $30.99M | -$125.31M | -$141.41M | -$2.63 | 21.63% | N/A | N/A | N/A | 2024-05-22 | |
ABCL | ABCELLERA BIOLOGICS INC | $1.18B | $38.03M | -$143.14M | -$146.40M | -$0.51 | -92.17% | 33.91% | N/A | N/A | 2024-06-13 | |
OVID | OVID THERAPEUTICS INC | $216.37M | $391.70k | -$50.74M | -$52.34M | -$0.74 | -73.93% | N/A | N/A | N/A | 2024-06-06 | |
EDIT | EDITAS MEDICINE INC | $463.88M | $78.12M | -$164.72M | -$153.22M | -$2.02 | 296.32% | 19.59% | N/A | N/A | 2024-05-31 | |
COCP | COCRYSTAL PHARMA INC | $16.58M | $0.00 | -$17.16M | -$17.98M | -$1.87 | N/A | N/A | N/A | N/A | 2024-05-13 | |
PALI | PALISADE BIO INC | $6.59M | $250.00k | -$12.20M | -$12.32M | -$27.00 | N/A | -0.78% | N/A | N/A | 2024-06-07 | |
CRNX | CRINETICS PHARMACEUTICALS INC | $3.28B | $4.01M | -$212.22M | -$214.53M | -$3.69 | -15.28% | 10.57% | N/A | N/A | 2024-05-09 | |
ALEC | ALECTOR INC | $516.09M | $97.06M | -$116.33M | -$130.39M | -$1.56 | -27.36% | 28.52% | N/A | N/A | 2024-06-12 | |
ALPN | ALPINE IMMUNE SCIENCES INC | $4.23B | $58.88M | -$31.41M | -$32.18M | -$0.64 | 95.84% | 142.30% | N/A | N/A | 2024-06-12 | |
STTK | SHATTUCK LABS INC | $512.60M | $2.72M | -$80.70M | -$85.08M | -$1.93 | 282.93% | N/A | N/A | N/A | 2024-06-07 | |
GERN | GERON CORP | $2.33B | $520.00k | -$190.52M | -$201.40M | -$0.35 | 5.26% | -8.37% | N/A | N/A | ||
GBIO | GENERATION BIO CO | $210.73M | $5.90M | -$121.35M | -$126.61M | -$1.96 | N/A | 177.31% | N/A | N/A | 2024-06-06 | |
MGNX | MACROGENICS INC | $978.31M | $58.75M | $5.51M | -$9.06M | -$0.15 | -61.33% | -0.46% | N/A | N/A | 2024-05-21 | |
PPBT | PURPLE BIOTECH LTD | $10.51M | $0.00 | $22.27M | $19.88M | N/A | N/A | -100.00% | N/A | N/A | 2024-06-14 | |
ABSI | ABSCI CORP | $572.95M | $5.72M | -$95.46M | -$110.57M | -$1.20 | -0.50% | N/A | N/A | N/A | 2024-06-12 | |
LUMO | LUMOS PHARMA INC | $24.00M | $2.05M | -$34.02M | -$34.03M | -$4.18 | 34.67% | -30.31% | N/A | N/A | 2024-05-06 | |
KYMR | KYMERA THERAPEUTICS INC | $2.29B | $79.41M | -$150.23M | -$154.59M | -$2.51 | 70.16% | N/A | N/A | N/A | 2024-06-18 | |
IMAB | I-MAB | $142.11M | $3.82M | -$195.33M | -$202.72M | -$2.44 | N/A | -12.91% | N/A | N/A | 2024-05-29 | |
MRNA | MODERNA INC | $47.90B | $5.15B | -$4.22B | -$5.97B | -$15.66 | -65.78% | 111.40% | N/A | N/A | 2024-05-06 | |
QURE | UNIQURE NV | $224.36M | $15.84M | -$253.10M | -$308.48M | -$6.47 | -85.12% | 7.02% | N/A | N/A | 2024-05-07 | |
CVKD | CADRENAL THERAPEUTICS INC | $7.84M | $0.00 | -$8.34M | -$8.36M | -$0.62 | N/A | N/A | N/A | N/A | ||
SXTP | 60 DEGREES PHARMACEUTICALS INC | $2.43M | $253.57k | -$1.38M | -$3.92M | -$0.99 | -50.40% | N/A | N/A | N/A | ||
NGNE | NEUROGENE INC | $470.80M | $0.00 | -$32.35M | -$36.32M | $27.76 | N/A | -100.00% | N/A | N/A | 2024-06-14 | |
BPMC | BLUEPRINT MEDICINES CORP | $6.71B | $282.21M | -$246.69M | -$288.29M | -$4.76 | 37.94% | 44.82% | N/A | N/A | 2024-06-12 | |
ATOS | ATOSSA THERAPEUTICS INC | $208.00M | $0.00 | -$30.07M | -$30.09M | -$0.24 | N/A | N/A | N/A | N/A | ||
EVGN | EVOGENE LTD | $35.92M | $5.64M | -$20.34M | -$23.88M | -$0.52 | 236.72% | 26.41% | N/A | N/A | 2024-05-10 | |
ELVN | ENLIVEN THERAPEUTICS INC | $936.52M | $0.00 | -$70.98M | -$71.58M | -$2.01 | N/A | N/A | N/A | N/A | 2024-06-18 | |
DTIL | PRECISION BIOSCIENCES INC | $72.76M | $48.73M | -$50.83M | -$61.32M | -$15.96 | 94.15% | 34.96% | N/A | N/A | 2024-06-04 | |
CLDX | CELLDEX THERAPEUTICS INC | $2.38B | $6.88M | -$138.42M | -$141.43M | -$2.92 | 192.02% | -6.32% | N/A | N/A | 2024-06-13 | |
DMAC | DIAMEDICA THERAPEUTICS INC | $113.87M | $0.00 | -$19.16M | -$19.30M | -$0.60 | N/A | -100.00% | N/A | N/A | 2024-05-08 | |
SVRA | SAVARA INC | $649.99M | $0.00 | -$50.09M | -$54.70M | -$0.33 | N/A | N/A | N/A | N/A | 2024-06-06 | |
TCRX | TSCAN THERAPEUTICS INC | $409.87M | $21.05M | -$80.10M | -$89.22M | -$1.36 | 55.52% | N/A | N/A | N/A | 2024-05-07 | |
AVXL | ANAVEX LIFE SCIENCES CORP | $316.13M | $0.00 | -$43.04M | -$43.16M | -$0.55 | N/A | N/A | N/A | N/A | 2024-05-09 | |
TBPH | THERAVANCE BIOPHARMA INC | $455.64M | $57.42M | -$40.77M | -$55.19M | -$1.00 | 11.84% | -1.00% | N/A | N/A | 2024-05-23 | |
DNTH | DIANTHUS THERAPEUTICS INC | $757.15M | $2.83M | -$43.20M | -$43.56M | -$8.45 | -55.96% | N/A | N/A | N/A | 2024-05-23 | |
NTBL | NOTABLE LABS LTD | $8.57M | $310.00k | -$10.28M | -$11.15M | -$3.41 | 3,775.00% | -11.93% | N/A | N/A | 2024-05-13 | |
CRDF | CARDIFF ONCOLOGY INC | $157.43M | $610.00k | -$39.82M | -$40.25M | -$0.90 | 54.43% | 12.39% | N/A | N/A | 2024-06-20 | |
TTNP | TITAN PHARMACEUTICALS INC | $6.29M | $184.00k | -$5.46M | -$5.57M | -$7.41 | -66.97% | -51.16% | N/A | N/A | 2024-06-28 | |
MOLN | MOLECULAR PARTNERS AG | $130.76M | $8.00M | -$61.83M | -$70.44M | -$2.15 | -95.89% | N/A | N/A | N/A | ||
LABP | LANDOS BIOPHARMA INC | $69.30M | $0.00 | -$21.94M | -$21.94M | -$3.50 | N/A | N/A | N/A | N/A | 2024-05-10 | |
PMCB | PHARMACYTE BIOTECH INC | $17.86M | $0.00 | -$1.14M | -$11.51M | -$1.20 | N/A | N/A | N/A | N/A | ||
FDMT | 4D MOLECULAR THERAPEUTICS INC | $1.31B | $20.72M | -$95.09M | -$100.84M | -$2.58 | 562.29% | 7.96% | N/A | N/A | 2024-05-21 | |
LSTA | LISATA THERAPEUTICS INC | $23.68M | $0.00 | -$22.98M | -$20.84M | -$2.58 | N/A | N/A | N/A | N/A | 2024-06-13 | |
TRVI | TREVI THERAPEUTICS INC | $208.26M | $0.00 | -$28.58M | -$29.07M | -$0.29 | N/A | N/A | N/A | N/A | 2024-06-13 | |
BOLT | BOLT BIOTHERAPEUTICS INC | $41.94M | $7.88M | -$64.39M | -$69.20M | -$1.83 | 37.48% | N/A | N/A | N/A | 2024-06-12 | |
ETNB | 89BIO INC | $862.08M | $0.00 | -$133.26M | -$142.19M | -$2.00 | N/A | N/A | N/A | N/A | 2024-05-29 | |
TVTX | TRAVERE THERAPEUTICS INC | $476.38M | $145.24M | -$61.31M | -$111.40M | -$1.50 | 32.69% | -2.43% | N/A | N/A | 2024-05-08 | |
AKRO | AKERO THERAPEUTICS INC | $1.11B | $0.00 | -$148.40M | -$151.76M | -$2.89 | N/A | N/A | N/A | N/A | 2024-05-13 | |
SNSE | SENSEI BIOTHERAPEUTICS INC | $44.88M | $0.00 | -$31.25M | -$34.10M | -$1.22 | N/A | N/A | N/A | N/A | 2024-05-07 | |
RIGL | RIGEL PHARMACEUTICALS INC | $210.45M | $116.88M | -$16.98M | -$25.09M | -$0.14 | -2.79% | 21.30% | N/A | N/A | 2024-05-07 | |
ATXS | ASTRIA THERAPEUTICS INC | $524.32M | $0.00 | -$72.89M | -$72.89M | -$2.42 | N/A | N/A | N/A | N/A | 2024-06-05 | |
DNA | GINKGO BIOWORKS HOLDINGS INC | $2.06B | $251.46M | -$792.98M | -$892.87M | -$0.46 | -47.36% | N/A | N/A | N/A | 2024-06-13 | |
TERN | TERNS PHARMACEUTICALS INC | $351.71M | $0.00 | -$89.09M | -$90.21M | -$1.27 | N/A | N/A | N/A | N/A | 2024-06-10 | |
ABIO | ARCA BIOPHARMA INC | $47.29M | $0.00 | -$5.90M | -$6.00M | -$0.42 | N/A | N/A | N/A | N/A | ||
IOBT | IO BIOTECH INC | $97.50M | $0.00 | -$84.48M | -$86.08M | -$1.98 | N/A | N/A | N/A | N/A | 2024-05-13 | |
CYCN | CYCLERION THERAPEUTICS INC | $8.01M | $0.00 | -$5.62M | -$5.26M | -$2.25 | -100.00% | N/A | N/A | N/A | 2024-05-09 | |
CABA | CABALETTA BIO INC | $597.71M | $0.00 | -$64.18M | -$67.68M | -$1.65 | N/A | N/A | N/A | N/A | 2024-06-03 | |
RXRX | RECURSION PHARMACEUTICALS INC | $2.07B | $44.58M | -$299.66M | -$328.07M | -$1.58 | 11.88% | N/A | N/A | N/A | 2024-05-20 | |
MNKD | MANNKIND CORP | $1.19B | $198.96M | $20.62M | -$11.94M | -$0.04 | 99.42% | 48.17% | N/A | N/A | 2024-05-08 | |
PHAR | PHARMING GROUP NV | $671.07M | $266.65M | $4.25M | -$11.47M | -$0.17 | 24.61% | 11.91% | N/A | N/A | 2024-05-21 | |
URGN | UROGEN PHARMA LTD | $487.95M | $82.71M | -$81.90M | -$102.24M | -$3.55 | 28.52% | 136.08% | N/A | N/A | 2024-05-09 | |
ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $436.73M | $170.28M | -$182.30M | -$225.25M | -$1.56 | -8.11% | 25.06% | N/A | N/A | 2024-05-07 |